|
Overview of myelodysplastic syndromes
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity
|
Jun 2017
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors
|
Jul 2017
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Iron Overload Alters the Energy Metabolism in Patients With Myelodysplastic Syndromes: Results From the Multicenter FISM BIOFER Study
|
Jun 2020
|
Scientific Reports
|
myelodysplastic syndromes (MDS)
|
|
Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes
|
Nov 2013
|
Sci Rep
|
myelodysplastic syndromes (MDS)
|
|
Treatment of eculizumab refractory paroxysmal nocturnal hemoglobinuria: A systematic review about current treatment options and future direction
|
Jun 2023
|
SAGE Open Medicine
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
New insight into myelodysplastic syndromes and related myeloid disorders.
|
May 2013
|
Rinsho Ketsueki
|
myelodysplastic syndromes (MDS)
|
|
Unrelated cord blood transplantation in a child with very severe aplastic anemia
|
Dec 2012
|
Rinsho Ketsueki
|
aplastic anemia
|
|
Relevance of prognostic factors in the decision-making of stem cell transplantation in Myelodysplastic Syndromes
|
Oct 2016
|
Rev Assoc Med Bras
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study
|
Nov 2016
|
Prostate
|
myelodysplastic syndromes (MDS)
|
